بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
improves decrease » improves disease (توسيع البحث), improved urease (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
improves decrease » improves disease (توسيع البحث), improved urease (توسيع البحث)
-
20741
-
20742
Table 1_Effects of two kinds of vestibular function training on reducing motion sickness in college students.docx
منشور في 2025"…Introduction<p>To explore the advantages and disadvantages of different vestibular function training to improve Motion sickness (MS) can be associated with significant symptoms, including fatigue, dizziness, headaches, nausea, and vomiting. …"
-
20743
Targeted screen of 20 conserved neuronal RBPs reveals eight novel associative memory regulators.
منشور في 2024"…Blue arrows indicate enhanced memory while pink arrows indicate decreased memory; lines indicate memory did not change. …"
-
20744
-
20745
-
20746
Effects of Ni<sup>2+</sup> on mitochondrial (A), glycolytic (B), and total (C) ATP production rates in BMDM.
منشور في 2025"…A double dagger (‡) indicates a significant decrease of mitochondrial ATP production rates (slope = −0.79 ± 0.21, <i>R</i><sup><i>2</i></sup> = 0.40, <i>F</i>(1, 22)=15.0, <i>p </i>< 0.001) from 0 to 72 ppm Ni<sup>2+</sup>. …"
-
20747
Image 1_Safety profile and efficacy of secukinumab in the treatment of autoimmune myasthenia gravis: a single-center retrospective study.jpeg
منشور في 2025"…Correlations between biomarkers and clinical improvements were analyzed.</p>Results<p>By week 24, secukinumab treatment led to significant reductions in disease severity scores (QMG: 60.7%; MG-QOL15: 58.3%; MG-ADL: 64.1%) and AChR antibody levels (69.23%). …"
-
20748
Data Sheet 1_Safety profile and efficacy of secukinumab in the treatment of autoimmune myasthenia gravis: a single-center retrospective study.pdf
منشور في 2025"…Correlations between biomarkers and clinical improvements were analyzed.</p>Results<p>By week 24, secukinumab treatment led to significant reductions in disease severity scores (QMG: 60.7%; MG-QOL15: 58.3%; MG-ADL: 64.1%) and AChR antibody levels (69.23%). …"
-
20749
Dot gain curves for three types of paper at different screen frequency.
منشور في 2025"…Dot gain initially increases and then decreases with rising dot area percentage, showing the most significant expansion in the mid-tone range (approximately 40%–60%) across coated, offset, and newsprint papers.…"
-
20750
Flowchart of inclusion of patients.
منشور في 2025"…Abnormalities detected included: 8.4% of patients with fasting blood glucose > 125 mg/dL, 7.5% with HbA1c > 6.5%, 1.9% with serum potassium < 3.5 mmoL/L, 54.2% with LDL Cholesterol > 100 mg/dL, 35.5% with serum creatinine > 0.8 mg/dL, and 7.5% with an estimated GFR < 60 mL/min/1.73 m2. Significant systolic blood pressure improvement was seen at 12 months in the complete workup group (129.9 ± 13.6 mmHg) vs. partial workup group (142.8 ± 18.9 mm Hg) (<i>P</i> = 0.003). …"
-
20751
Differences in testing between men and women.
منشور في 2025"…Abnormalities detected included: 8.4% of patients with fasting blood glucose > 125 mg/dL, 7.5% with HbA1c > 6.5%, 1.9% with serum potassium < 3.5 mmoL/L, 54.2% with LDL Cholesterol > 100 mg/dL, 35.5% with serum creatinine > 0.8 mg/dL, and 7.5% with an estimated GFR < 60 mL/min/1.73 m2. Significant systolic blood pressure improvement was seen at 12 months in the complete workup group (129.9 ± 13.6 mmHg) vs. partial workup group (142.8 ± 18.9 mm Hg) (<i>P</i> = 0.003). …"
-
20752
General characteristics of patients.
منشور في 2025"…Abnormalities detected included: 8.4% of patients with fasting blood glucose > 125 mg/dL, 7.5% with HbA1c > 6.5%, 1.9% with serum potassium < 3.5 mmoL/L, 54.2% with LDL Cholesterol > 100 mg/dL, 35.5% with serum creatinine > 0.8 mg/dL, and 7.5% with an estimated GFR < 60 mL/min/1.73 m2. Significant systolic blood pressure improvement was seen at 12 months in the complete workup group (129.9 ± 13.6 mmHg) vs. partial workup group (142.8 ± 18.9 mm Hg) (<i>P</i> = 0.003). …"
-
20753
Percentage of testing based on smoking status.
منشور في 2025"…Abnormalities detected included: 8.4% of patients with fasting blood glucose > 125 mg/dL, 7.5% with HbA1c > 6.5%, 1.9% with serum potassium < 3.5 mmoL/L, 54.2% with LDL Cholesterol > 100 mg/dL, 35.5% with serum creatinine > 0.8 mg/dL, and 7.5% with an estimated GFR < 60 mL/min/1.73 m2. Significant systolic blood pressure improvement was seen at 12 months in the complete workup group (129.9 ± 13.6 mmHg) vs. partial workup group (142.8 ± 18.9 mm Hg) (<i>P</i> = 0.003). …"
-
20754
Original values used to build graphs.
منشور في 2025"…Joint analysis of RNA-seq and m<sup>6</sup>A-seq data was utilized for enriching differentially expressed genes (DEGs) with significantly altered m<sup>6</sup>A modifications. Intriguingly, following <i>T. gondii</i> infection, the m<sup>6</sup>A levels of DEGs associated with toxoplasmosis, TNF signaling pathway, and NF-κB signaling pathway were significantly different. …"
-
20755
Kaplan-Meier plot.
منشور في 2024"…The risk of developing leprosy among contacts was significantly lower in the intervention districts (HR 0.28, 95% CI 0.18–0.44). …"
-
20756
Characteristics of the study sample.
منشور في 2024"…The risk of developing leprosy among contacts was significantly lower in the intervention districts (HR 0.28, 95% CI 0.18–0.44). …"
-
20757
Multivariate associations with incident leprosy.
منشور في 2024"…The risk of developing leprosy among contacts was significantly lower in the intervention districts (HR 0.28, 95% CI 0.18–0.44). …"
-
20758
Univariate associations with incident leprosy.
منشور في 2024"…The risk of developing leprosy among contacts was significantly lower in the intervention districts (HR 0.28, 95% CI 0.18–0.44). …"
-
20759
Flowchart of study population.
منشور في 2025"…Subgroup analysis showed no significant interactions. Similar results were obtained when analyzing the association of maximum PLT(PLT-max) and mortality rate.…"
-
20760
Comparison of dot gain across paper types and screen frequency.
منشور في 2025"…Dot gain curves for 133 lpi and 175 lpi show a consistent non-linear trend, rising to a maximum in the mid-tone range (40%–60% dot area) before decreasing. Mid-tone regions exhibited the most significant dot gain across all paper types.…"